ENHANCED MALARIA MSP-1 SUBUNIT VACCINE
Recombinant subunit proteins derived from the MSP-1 C-terminal region of the parasite Plasmodium falciparum are described that have enhanced immunogenic properties. Selected regions of p33 have been combined with p19 to enhance the immunogenic potential of the p19 core region. As the constructs represent discontinuous segments fused to create unique proteins, the recombinant proteins expressed are not found in nature. The enhanced immunogenic potential of the disclosed recombinant proteins provided for strong, consistent and specific antibody responses. The disclosed recombinant subunit proteins are vaccine candidates for protection against infection with malaria.
1 . MSP-1 C-terminal recombinant subunit proteins with enhanced immunogenic properties comprising:
the p19 core region of the Plasmodium falciparum MSP-1 protein of the C-terminal region to which selected segments of the p33 region have been added; and
the expression and secretion of said recombinant subunit proteins from a cell based expression system.
2 . The recombinant subunit proteins of claim 1 , wherein the enhanced immunogenic properties are measured as increased and consistent parasite growth inhibition activity.
3 . The recombinant subunit proteins of claim 2 , wherein all animals immunized result in in parasite growth inhibition activity greater than 50%.
4 . The recombinant subunit proteins of claim 1 , wherein the subunits are derived by deletions of the N-terminus of the p33 region shown in SEQ. ID. NO: 1, SEQ. ID. NO: 2, SEQ. ID. NO: 5, SEQ. ID. NO:7 and SEQ. ID. NO: 17.
5 . The recombinant subunit proteins of claim 1 , wherein the subunits are derived by linkage of selected p33 region fragments shown in SEQ. ID. NO: 8, SEQ. ID. NO: 11, SEQ. ID. NO:
14, and SEQ. 1D. NO: 18.
6 . The expression of the recombinant subunit proteins of claim 1 , wherein the expression system is a eukaryotic cell culture system.
7 . The expression of the recombinant subunit proteins of claim 6 , wherein the cell culture expression system utilizes insect cells.
8 . The expression of the recombinant subunit proteins of claim 7 , wherein the insect cells are Drosophila S2 cells.
9 . Vaccine formulations comprising MSP-1 C-terminal subunit proteins capable of eliciting protection from malaria infection.
10 . The vaccine formulations of claim 9 , wherein the MSP-1 C-terminal subunit proteins shown in SEQ. ID. NO: 1, SEQ. ID. NO: 2, SEQ. ID. NO: 5, SEQ. ID. NO:7 SEQ. ID. NO: 8, SEQ. ID. NO: 11, SEQ. ID. NO: 14, SEQ. ID. NO:17 and SEQ. ID. NO: 18.